TAKEDA BELGIUM
Naamloze vennootschap (NV) · Zaventem, Belgium · LEI 894500TFSGY31Z5ZM673
LEI lapsed
Summary
TAKEDA BELGIUM is registered in Belgium and entered in the “Crossroads Bank for Enterprises (KBO/BCE)” under number 0403054202. Its legal form is Naamloze vennootschap (NV) – public limited company (Belgium). According to GLEIF, its ultimate parent is 武田薬品工業株式会社 (Japan), which is also its direct parent. That group has 11 subsidiaries with LEIs in 9 countries, 1 of them in Belgium. The LEI was first issued on 27 Mar 2020 and the record was last updated on 28 Mar 2024. It has lapsed: renewal was due by 27 Mar 2024. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 27 Mar 2024 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Mar 2022, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 28 Mar 2024.
Company details
| Legal form | Naamloze vennootschap (NV) public limited company (Belgium) |
|---|---|
| Register | Crossroads Bank for Enterprises (KBO/BCE) · Register website |
| Registration number | 0403054202 |
| Registration authority | Federal Public Service Economy (Ministry of Economy) |
| Jurisdiction | Belgium |
| Registered address | Da Vincilaan 7, 1930 Zaventem, Belgium |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 11 Jun 1945 |
| LEI | 894500TFSGY31Z5ZM673 |
| LEI status | lapsed |
| LEI first issued | 27 Mar 2020 |
| LEI record last updated | 28 Mar 2024 |
| Next LEI renewal | 27 Mar 2024 |
| Corroboration of the LEI record | fully corroborated |
Group membership
TAKEDA BELGIUM this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | 武田薬品工業株式会社 | 武田薬品工業株式会社 |
| Accounting period | 1 Apr 2021 to 31 Mar 2022 | 1 Apr 2021 to 31 Mar 2022 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Accounting standard | IFRS | IFRS |
| Relationship start | 1 Apr 2017 | 1 Apr 2017 |
| Recorded at GLEIF since | 3 Jun 2020 | 27 Mar 2020 |
| Last updated | 28 Mar 2024 | 28 Mar 2024 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (7)
- Baxalta Innovations GmbH Austria
- BioLife Plazma Hungary Korlátolt Felelősségű Társaság Hungary
- Takeda Manufacturing Austria AG Austria
- Takeda Pharmaceuticals Czech Republic s.r.o Czechia
- Takeda Pharmaceuticals International AG Switzerland
- TAKEDA PHARMACEUTICALS U.S.A., INC. United States lapsed
- TAKEDA U.S. FINANCING, INC. United States